Article | May 30, 2025

Speeding To Success: Accelerating Cell Therapy Development And Manufacturing Workflows

Thermo - accelerating CGT

Many cell therapy developers are held back by outdated and inefficient processes that can't meet the demands of today's rapidly innovating market. These legacy systems often lack the automation, flexibility, and scalability required to meet increasingly stringent regulatory requirements, leading to potential delays and inconsistencies. To truly accelerate workflows, next-generation solutions are needed.

Advanced, automated systems can significantly reduce processing times—for instance, cutting bead removal from five hours to under one hour—while lowering the risk of contamination and human error. Furthermore, modular instrumentation enables a seamless transition from development to commercial production, helping to avoid costly delays.

Access the article to learn how a trusted supplier can help you overcome limitations and enhance therapeutic efficacy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction